相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Modulation of Wnt Activity and Cell Physiology by Butyrate in LT97 Microadenoma Cells
Darina Lazarova et al.
JOURNAL OF CANCER (2014)
Metastatic SW620 colon cancer cells are primed for death when detached and can be sensitized to anoikis by the BH3-mimetic ABT-737
A. Maamer-Azzabi et al.
CELL DEATH & DISEASE (2013)
Murine Colitis is Mediated by Vimentin
Nirit Mor-Vaknin et al.
SCIENTIFIC REPORTS (2013)
p300 Influences Butyrate-Mediated WNT Hyperactivation In Colorectal Cancer Cells
Darina L. Lazarova et al.
JOURNAL OF CANCER (2013)
Tcf3 and cell cycle factors contribute to butyrate resistance in colorectal cancer cells
Christopher Chiaro et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Molecular insight in the multifunctional activities of Withaferin A
Wim Vanden Berghe et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells
Joomin Lee et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Wnt Signaling through Inhibition of β-Catenin Degradation in an Intact Axin1 Complex
Vivian S. W. Li et al.
CELL (2012)
Withaferin A Alters Intermediate Filament Organization, Cell Shape and Behavior
Boris Grin et al.
PLOS ONE (2012)
Vimentin in cancer and its potential as a molecular target for cancer therapy
Arun Satelli et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
A Switch from Canonical to Noncanonical Wnt Signaling Mediates Drug Resistance in Colon Cancer Cells
Michael Bordonaro et al.
PLOS ONE (2011)
p21Waf1 expression is regulated by nuclear intermediate filament vimentin in neuroblastoma
Xenia Mergui et al.
BMC CANCER (2010)
Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition
Melissa G. Mendez et al.
FASEB JOURNAL (2010)
Notch-1 Inhibition by Withaferin-A: A Therapeutic Target against Colon Carcinogenesis
Srinivas Koduru et al.
MOLECULAR CANCER THERAPEUTICS (2010)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
Vimentin Is a Novel Anti-Cancer Therapeutic Target; Insights from In Vitro and In Vivo Mice Xenograft Studies
Guy Lahat et al.
PLOS ONE (2010)
3,3′-Diindolylmethane Enhances the Efficacy of Butyrate in Colon Cancer Prevention through Down-Regulation of Survivin
Namrata Bhatnagar et al.
CANCER PREVENTION RESEARCH (2009)
Vimentin Inhibits ATF4-mediated Osteocalcin Transcription and Osteoblast Differentiation
Na Lian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Intestinal adenomagenesis involves core molecular signatures of the epithelial-mesenchymal transition
Xiaodi Chen et al.
JOURNAL OF MOLECULAR HISTOLOGY (2008)
Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion
Lorna McInroy et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin
Paola Bargagna-Mohan et al.
CHEMISTRY & BIOLOGY (2007)
The activation of beta-catenin by Wnt signaling mediates the effects of histone deacetylase inhibitors
Michael Bordonaro et al.
EXPERIMENTAL CELL RESEARCH (2007)
Absence of p300 induces cellular phenotypic changes characteristic of epithelial to mesenchyme transition
D Krubasik et al.
BRITISH JOURNAL OF CANCER (2006)
Intermediate filament proteins participate in signal transduction
BT Helfand et al.
TRENDS IN CELL BIOLOGY (2005)
The gut fermentation product butyrate, a chemopreventive agent, suppresses glutathione S-transferase theta (hGSTT1) and cell growth more in human colon adenoma (LT97) than tumor (HT29) cells
T Kautenburger et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2005)
Linear relationship between WNT activity levels and apoptosis in colorectal carcinoma cells exposed to butyrate
DL Lazarova et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study
SA Bingham et al.
LANCET (2003)
Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme
U Peters et al.
LANCET (2003)
Cells obtained from colorectal microadenomas mirror early premalignant growth patterns in vitro
M Richter et al.
EUROPEAN JOURNAL OF CANCER (2002)
The 'just-right' signaling model:: APC somatic mutations are selected based on a specific level of activation of the β-catenin signaling cascade
C Albuquerque et al.
HUMAN MOLECULAR GENETICS (2002)
分享论文
